MktsMarkets

Nephros, Inc.
NASDAQ: NEPHKey statistics
NEPH News
Stories mentioning NEPH from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 5,212 | 4,729 | 4,764 | 4,419 | 4,877 | 3,870 | 3,518 | 3,252 |
| Cost of Goods Sold | 2,219 | 1,968 | 1,849 | 1,624 | 1,723 | 1,395 | 1,369 | 1,340 |
| Gross Profit | 2,993 | 2,761 | 2,915 | 2,795 | 3,154 | 2,475 | 2,149 | 1,912 |
| Operating Expenses | ||||||||
| Research & Development | 346.00 | 395.00 | 338.00 | 311.00 | 295.00 | 252.00 | 188.00 | 254.00 |
| Sales General & Admin | 2,521 | 2,316 | 2,229 | 2,201 | 2,254 | 1,872 | 1,721 | 1,941 |
| Total Operating Expenses | 2,896 | 2,743 | 2,601 | 2,547 | 2,588 | 2,158 | 1,943 | 2,229 |
| Operating Income (Loss) | 97.00 | 18.00 | 314.00 | 248.00 | 566.00 | 317.00 | 206.00 | (317.00) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 11.00 | (10.00) | (15.00) | (32.00) | (21.00) | 19.00 | (43.00) | 7.00 |
| Pretax Income | 340.00 | 246.00 | 183.00 | (289.00) | ||||
| Tax Provision | 0.00 | 0.00 | 3.00 | 9.00 | 0.00 | 15.00 | 0.00 | 0.00 |
| Net Income (Loss) | 140.00 | 62.00 | 337.00 | 237.00 | 558.00 | 349.00 | 183.00 | (289.00) |
| Earnings Per Share (Basic) | 0.01 | 0.01 | 0.03 | 0.02 | 0.05 | 0.03 | 0.02 | (0.03) |
| Earnings Per Share (Diluted) | 0.01 | 0.01 | 0.03 | 0.02 | 0.05 | 0.03 | 0.02 | (0.03) |
| Weighted Average Shares Outstanding (Basic) | 10,651 | 10,612 | 10,612 | 10,600 | 10,600 | 10,525 | 10,544 | 10,510 |
| Weighted Average Shares Outstanding (Diluted) | 10,991 | 10,968 | 11,041 | 10,813 | 10,616 | 10,602 | 10,581 | 10,510 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About NEPH
Nephros, Inc. (NASDAQ: NEPH) is a stock listed on the Nasdaq Stock Market under the ticker symbol NEPH. It last traded at $3.25 (Nov 4, 2026, 4:00 PM ET), up 0.3% on the day. That gives Nephros a market capitalisation of $34.9M and a price-to-earnings ratio of 20.1.
Over the past 52 weeks NEPH has traded between $2.66 and $6.42.
Revenue for the quarter ended Mar 31, 2026 was $5.2M; net income $140.0K. Revenue was up 6.9% from $4.9M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $5.2M | $140.0K | 2.7% |
| Dec 31, 2025 | $4.7M | $62.0K | 1.3% |
| Sep 30, 2025 | $4.8M | $337.0K | 7.1% |
| Jun 30, 2025 | $4.4M | $237.0K | 5.4% |
From Nephros’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…